Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation
复制标题
DOI:
10.1016/j.bbmt.2005.12.033
复制
发表时间:
2006-05-01
影响因子:
4.3
通讯作者:
Rizzo, JD
中科院分区:
文献类型:
--
作者:
Navarro, WH;Loberiza, FR;Rizzo, JD
High-dose therapy with autologous hematopoietic cell transplantation (auto-HT) is frequently used to improve outcomes in lymphoma. However, small studies suggest a survival disadvantage among obese patients. Using a retrospective cohort analysis, we studied the outcomes of 4681 patients undergoing auto-HCT for Hodgkin or non-Hodgkin lymphoma between 1990 and 2000 according to body mass index (BMI). Four groups categorized by BMI were compared by using Cox proportional hazards regression to adjust for other prognostic factors. A total of 1909 patients were categorized as normal weight (BMI 18-25 kg/m(2)), 121 as underweight (BMI > 18 kg/m(2)), 1725 as overweight (BMI > 25-30 kg/m(2)), and 926 as obese (BMI > 30 kg/m(2)) at the time of HCT. Outcomes evaluated included overall survival, relapse, transplantation-related mortality TRM underweight group had a higher risk of TRIM (relative risk [RR], 2.46; 95% confidence interval [CI], 1.59-3.82; P < 0.0001) compared with the normal-BMI group. No differences in relapse were noted. Overall mortality was higher in the under-weight group (RR, 1.48; 95% CI, 1.17-1.88; P=.001) and lower in the overweight (RR, 0.87; 95% CI, 0.79-0.96; P=.004) and obese (RR, 0.76; 95% CI, 0.67-0.86; P